Bucumolol

CAS No. 58409-59-9

Bucumolol( —— )

Catalog No. M34535 CAS No. 58409-59-9

Bucumolol (Bucumarol) is a β-adrenergic blocking agent and a local anesthetic with antihypertensive activity and can be used to study myocardial infarction.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 459 Get Quote
10MG 657 Get Quote
25MG 994 Get Quote
50MG 1371 Get Quote
100MG 1773 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Bucumolol
  • Note
    Research use only, not for human use.
  • Brief Description
    Bucumolol (Bucumarol) is a β-adrenergic blocking agent and a local anesthetic with antihypertensive activity and can be used to study myocardial infarction.
  • Description
    Bucumolol (Bucumarol) is a β-adrenergic blocking agent and a local anesthetic with antihypertensive activity and can be used to study myocardial infarction.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    58409-59-9
  • Formula Weight
    305.37
  • Molecular Formula
    C17H23NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1OC2=C(OCC(O)CNC(C)(C)C)C=CC(=C2C=C1)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • ADRA1D receptor anta...

    ADRA1D receptor antagonist 1 HCl is an orally active, potent and selective α1D adrenergic receptor antagonist (Ki: 1.6 nM) with potential antiproliferative activity.

  • CGP-20712

    CGP-20712 is a selective β 1-adrenoceptor antagonist with an IC50 of 0.7 nM.

  • Metoprolol succinate

    A selective β1 receptor blocker used in treatment of several diseases of the cardiovascular system, especially hypertension.